Mizukami Y, Sakaue H
Third Department of Internal Medicine, School of Medicine, Ehime University.
Nihon Rinsho. 1994 Jan;52(1):91-6.
Gastroduodenal lesions are a common complication in patients with liver cirrhosis. The etiology of this problem has been investigated from the standpoint of both mucosal protective factors and aggressive factors. Among the various mucosal protective factors, much emphasis has been placed on the disturbance of microcirculation in the gastric mucosa as a result of stasis in the portal vein. Duodenogastric reflux may be involved in the etiology of the gastric mucosal changes. And, Phospholipids levels in the gastric mucosa were reduced in cirrhosis. Regarding aggressive factors, there have been many reports of diminished secretion of gastric acid. But, patients with ulcer had a tendency to be higher gastric acidity than those without ulcer. Drugs increased mucosal defense might be effective in healing gastroduodenal lesions in cirrhosis. Despite the observation that acid secretion decreased in cirrhosis, inhibition of acid secretion induces ulcer healing. In cirrhosis, a high incidence of gastric cancer was reported, so that patients should be undergo periodic screening with endoscopy.
胃十二指肠病变是肝硬化患者常见的并发症。已从黏膜保护因素和侵袭性因素两方面对该问题的病因进行了研究。在各种黏膜保护因素中,门静脉淤血导致胃黏膜微循环紊乱备受关注。十二指肠-胃反流可能参与了胃黏膜改变的病因。而且,肝硬化患者胃黏膜中的磷脂水平降低。关于侵袭性因素,有许多关于胃酸分泌减少的报道。但是,溃疡患者的胃酸度往往高于无溃疡患者。增加黏膜防御的药物可能对治疗肝硬化患者的胃十二指肠病变有效。尽管观察到肝硬化患者胃酸分泌减少,但抑制胃酸分泌可促进溃疡愈合。在肝硬化患者中,胃癌的发病率较高,因此患者应定期接受内镜筛查。